Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags AstraZeneca PLC Pharmaceutical industry regulation Pets
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags LVMH Moet Hennessy Louis Vuitton SE Europe Markets Sanofi SA
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Breaking News: Markets Zealand Pharma A/S Pharmaceuticals
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Health care industry Eli Lilly and Co Personnel
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Pfizer Inc Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Biotechnology US: News Catalent Inc
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Health & Science Investing Europe Markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Novo Nordisk A/S Qualcomm Inc Politics
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Biotechnology US: News Companies
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Roche Holding AG Viking Therapeutics Inc Health care industry
From CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags Investment strategy Investing Novo Nordisk A/S
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags AstraZeneca PLC Social issues Biotechnology
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Stock markets Insulet Corp stocks
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Business Pharmaceuticals US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Novo Nordisk A/S Pfizer Inc Markets
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Business News Health & Science AstraZeneca PLC
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Pharmaceuticals Business Breaking news
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Companies US: News Biotechnology
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Breaking News: Investing Breaking News: Markets LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Mad Money Eli Lilly and Co Stock Picks
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Eli Lilly and Co Health care industry Eisai Co Ltd
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Business Weight management Pharmaceuticals
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Eli Lilly and Co Health care industry Novo Nordisk A/S
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags US: News Companies Biotechnology
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Stock markets stocks Investment Strategy
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Business Pharmaceuticals Breaking news
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Gap Inc Markets
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Business News Novo Nordisk A/S Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.